Global Prothrombin Complex Concentrate Market Report By Product (3-Factor PCC, 4-Factor PCC, Others), By Application (Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency , Others), By End Use (Hospitals, Ambulatory Surgical Centres, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214580
April 2021
Report Formats:
The global demand for Prothrombin Complex Concentrate Market is presumed to reach the market size of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period 2021 - 2027.

Prothrombin complex concentrate is a hemostatic blood product used as medication. It is made up of blood clotting factors II, IX, X, and sometimes factor VII. This concentrate has the ability to reverse the effects of warfarin and other vitamin K anticoagulants. It is used in significant bleeding cases in people with coagulopathy or when such patients undergo an emergency operation treatment. It is also used in people with a deficiency of one of the clotting factors because of congenital, liver disease, or hemophilia. It is administered using a slow injection directly into the human vein. It is produced by the ion-exchange chromatography of the cryoprecipitate supernatant of large plasma pools and antithrombin and factor XI removal. 

Market Dynamics 

The increased prevalence of bleeding disorders and eased government approval for innovative medical therapies are few driving factors favoring the market growth. The rising demand for PCC for treating unwanted excessive bleeding during surgical procedures due to its high clinical efficiency will benefit the market’s growth. The growing use of warfarin therapy and the high efficiency of prothrombin complex concentrates in rapidly reversing coagulopathy in patients with warfarin-related intracranial hemorrhage will enhance the market growth. Increased investments in the research and development of new drugs to treat blood clotting disorders and improving healthcare infrastructure will be a market booster. Lack of awareness and the side effects of these medications can have a burdening impact on market growth.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of prothrombin complex concentrate. The growth and trends of prothrombin complex concentrate industry provide a holistic approach to this study. 

Market Segmentation

This section of the prothrombin complex concentrate market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product
  • 3-Factor PCC
  • 4-Factor PCC
  • Others
By Application
  • Acquired Coagulation Factor Deficiency
  • Congenital Coagulation Factor Deficiency 
  • Others
By End Use
  • Hospitals
  • Ambulatory Surgical Centres
  • Others
Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Prothrombin Complex Concentrate market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Prothrombin Complex Concentrate Market Share by Region (Representative Graph)

Global Prothrombin Complex Concentrate Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the prothrombin complex concentrate market include Novo Nordisk, China Biologic Products Holdings Inc., Baxter, Grifols, Shire US Inc., Kedrion S.p.A, Octapharma AG, CSL Behring, Takeda Pharmaceutical Company Limited, Sanquin. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . PROTHROMBIN COMPLEX CONCENTRATE – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product
           3.7.2 By Application
           3.7.3 By End Use
           3.7.4 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL PROTHROMBIN COMPLEX CONCENTRATE MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 3-Factor PCC Market by Regions
       6.5 4-Factor PCC Market by Regions
       6.6 Others Market by Regions
 
7 . GLOBAL PROTHROMBIN COMPLEX CONCENTRATE MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Application
       7.4 Acquired Coagulation Factor Deficiency Market by Regions
       7.5 Congenital Coagulation Factor Deficiency  Market by Regions
       7.6 Others Market by Regions
 
8 . GLOBAL PROTHROMBIN COMPLEX CONCENTRATE MARKET ANALYSIS BY END USE
       8.1 Overview by End Use
       8.2 Historical and Forecast Data
       8.3 Analysis by End Use
       8.4 Hospitals Market by Regions
       8.5 Ambulatory Surgical Centres Market by Regions
       8.6 Others Market by Regions
 
9 . GLOBAL PROTHROMBIN COMPLEX CONCENTRATE MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
           9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE PROTHROMBIN COMPLEX CONCENTRATE COMPANIES
       10.1. Prothrombin Complex Concentrate Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF PROTHROMBIN COMPLEX CONCENTRATE INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Novo Nordisk
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. China Biologic Products Holdings Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Baxter
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Grifols
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Shire US Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Kedrion S.p.A.
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Octapharma AG
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. CSL Behring
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Takeda Pharmaceutical Company Limited
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Sanquin
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product (USD MN)
  • 3-Factor PCC Market by Geography (USD MN)
  • 4-Factor PCC Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Acquired Coagulation Factor Deficiency Market by Geography (USD MN)
  • Congenital Coagulation Factor Deficiency  Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by End Use (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Ambulatory Surgical Centres Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Prothrombin Complex Concentrate Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Prothrombin Complex Concentrate Report
  • Market Research Process
  • Market Research Methodology
  • Global Prothrombin Complex Concentrate Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • 3-Factor PCC Market by Geography (USD MN)
  • 4-Factor PCC Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Acquired Coagulation Factor Deficiency Market by Geography (USD MN)
  • Congenital Coagulation Factor Deficiency  Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by End Use (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Ambulatory Surgical Centres Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials